DM (n = 219) | Non-DM (n = 289) | ||||||||
---|---|---|---|---|---|---|---|---|---|
DCB-based treatment | DES-only treatment | HR (95% CI) | p Value* | DCB-based treatment | DES-only treatment | HR (95% CI) | p Value* | ||
(n = 104) | (n = 115) | (n = 150) | (n = 139) | ||||||
MACE | 3 (2.9) | 16 (13.9) | 0.19 (0.05–0.68) | 0.003 | 7 (4.7) | 12 (8.6) | 0.52 (0.20–1.38) | 0.167 | |
Cardiac death | 0 | 4 (3.5) | - | 0.044 | 1 (0.7) | 2 (1.4) | 0.43 (0.03–5.34) | 0.481 | |
Myocardial infarction | 0 | 1 (0.9) | - | 0.290 | 0 | 2 (1.4) | - | 0.155 | |
Stroke | 0 | 1 (0.9) | - | 0.333 | 0 | 0 | - | - | |
Stent or target lesion thrombosis | 0 | 0 | - | - | 0 | 1 (0.7) | - | 0.316 | |
Target vessel revascularization | 2 (1.9) | 8 (7.0) | 0.27 (0.05–1.34) | 0.077 | 6 (4.0) | 8 (5.8) | 0.69 (0.23–2.07) | 0.492 | |
Major bleeding | 1 (1.0) | 4 (3.5) | 0.26 (0.03–2.34) | 0.196 | 0 | 3 (2.2) | - | 0.063 |